Home | Products | News | Contact Us
   

Nutraceutical News

Australia rethinks nutrient labelling and health claims standards
EFSA approves new vitamins and minerals for foods and supplements
Children positive on organic, free-range and hormone-free
Calcium sales growth suffering from lack of novelty
West follow East's functional lead?
Women Looking For An Alternative To Black Cohosh






 

Sesamin Clinical Study


The sesame seed oil constituent, sesamol, induces growth arrest and apoptosis of cancer and cardiovascular cells.

Jacklin A, Ratledge C, Welham K, Bilko D, Newton CJ.

Biological Sciences and Department of Chemistry, University of Hull, Hull, United Kingdom.

Sesamol is a potent inhibitor of fungal fatty acid biosynthesis. This effect is apparently due to inhibition of malic enzyme and the supply of NADPH that is required for this biosynthetic pathway. It is the ability of sesamol to reduce the synthesis of the coenzyme, NADPH, that makes it attractive for use in studying the effect of oxidants on tumor and vascular endothelial cells. By conducting preliminary studies on the effect of sesamol alone, it was clear that the compound demonstrated marked cytotoxicity. This paper describes the experiments performed.

PMID: 15033755 [PubMed - indexed for MEDLINE]


<< Back to All Natural Products List

© Copyright 2007 - Nutraceutical Ingredients - All Rights Reservec